You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pharmacodynamic

Showing 1 - 25 of 5,954
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aged Trial in Santiago (Propofol)

Not yet recruiting
  • Aged
  • Santiago, Región Metropolitana, Chile
    Pontificia Universidad Católica de Chile
Mar 16, 2023

Healthy Subjects Trial in Melbourne (AP301)

Not yet recruiting
  • Healthy Subjects
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Oct 20, 2023

Pharmacodynamic Trial in Salt Lake City (Nalmefene HCl, Naloxone HCl)

Completed
  • Pharmacodynamic
  • Nalmefene hydrochloride
  • Naloxone hydrochloride
  • Salt Lake City, Utah
    PRA Health Sciences
Dec 8, 2022

Levamlodipine Benzoate and Its Population Pharmacodynamic

Active, not recruiting
  • Hypertensive Patients
  • Monotherapy
  • blood pressure control
  • Chongqing, China
    Yu Xian
Jul 20, 2023

/Pharmacodynamic Models in Kidney Transplant Patients

Active, not recruiting
  • Kidney Transplantation
  • Immunosuppressive Agents
    • Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    May 15, 2023

    Pharmacodynamic Models of Chronic Disease Therapeutics for

    Recruiting
    • Chronic Disease
    • Smoking
    • Smoking
    • non-somking
    • Chongqing, China
      Yu Xian
    Dec 18, 2022

    To Reduce the LDL-C Level in Hypercholesteremia Patients Trial (RN0191)

    Not yet recruiting
    • To Reduce the LDL-C Level in Hypercholesteremia Patients
    • (no location specified)
    Nov 13, 2023

    Healthy Trial in Seoul (ID120040002, Compound-X, Placebo comparator)

    Recruiting
    • Healthy
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Dec 21, 2022

    Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)

    Not yet recruiting
    • Coronary Artery Disease
    • Platelet Reactivity
    • (no location specified)
    Mar 7, 2023

    Healthy Trial in Wuxi (HHT120, Placebo)

    Withdrawn
    • Healthy
    • Wuxi, Jiangsu, China
      Affiliated Hospital of Jiangnan University
    Jan 30, 2023

    To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other

    Not yet recruiting
    • To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
    • Combination for Subgroup High LDL-c Patients With Other Comorbidities
    • RN0191 INJECTION
    • (no location specified)
    Jun 14, 2023

    Cannabis, Drug Effects Trial in Baltimore (CBD, THC)

    Recruiting
    • Cannabis, Drug Effects
    • Baltimore, Maryland
      Johns Hopkins University
    Sep 21, 2022

    Nicotine Withdrawal, Nicotine Addiction, Drug Effect Trial in Baltimore (Nicotine, Cigarette)

    Recruiting
    • Nicotine Withdrawal
    • +2 more
    • Nicotine
    • Cigarette
    • Baltimore, Maryland
      Johns Hopkins Behavioral Pharmacology Research Unit
    Dec 7, 2022

    HEAD & NECK Cancer Trial in New York (ribavirin)

    Active, not recruiting
    • HEAD & NECK Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 11, 2023

    Ischemic Stroke, Acute Trial (Yiqihuayu Decotion)

    Not yet recruiting
    • Ischemic Stroke, Acute
    • Yiqihuayu Decotion
    • (no location specified)
    Sep 24, 2022

    Healthy Participants Trial in Glendale (ID119031166M, Placebo)

    Recruiting
    • Healthy Participants
    • Glendale, California
      California Clinical trials medical group/PAREXEL
    Oct 28, 2022

    Infectious Disease, Therapeutics Trial in Vientiane (Doxycyclin, Azithromycin)

    Not yet recruiting
    • Infectious Disease
    • Therapeutics
    • Vientiane, Vientaine, Lao People's Democratic Republic
      Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU
    Jul 31, 2023

    Percutaneous Coronary Intervention Trial in Napoli (Cangrelor)

    Recruiting
    • Percutaneous Coronary Intervention
    • Napoli, Italy
      University Federico II of Naples
    Jul 25, 2022

    Neuropathy;Peripheral, Chemo-induced Peripheral Neuropathy Trial in Cincinnati (BXQ-350, Placebo)

    Recruiting
    • Neuropathy;Peripheral
    • Chemotherapy-induced Peripheral Neuropathy
    • Cincinnati, Ohio
      CTI Clinical Research Center
    Oct 28, 2022

    Diabetes, Type 2 Trial in Graz (Insulin Icodec)

    Completed
    • Diabetes Mellitus, Type 2
    • Insulin Icodec
    • Graz, Austria
      Novo Nordisk Investigational Site
    Nov 4, 2022

    Colorectal Tumors Trial in Melbourne (CS-1008)

    Completed
    Has Results
    • Colorectal Neoplasms
    • Melbourne, Victoria, Australia
      Ludwig Institute Tumor Targeting Program, Austin Health
    Oct 3, 2022

    Cystic Fibrosis Trial in Cincinnati (Ceftaroline)

    Active, not recruiting
    • Cystic Fibrosis
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Aug 29, 2022

    CNS Effects of Diphenhydramine, Pharmacokinetics of Diphenhydramine Trial in Amherst (DiphenhydrAMINE Injectable Solution)

    Terminated
    • Central Nervous System Effects of Diphenhydramine
    • Pharmacokinetics of Diphenhydramine
    • DiphenhydrAMINE Injectable Solution
    • Amherst, New York
      Dent Neurologic Institute
    Oct 4, 2022

    Glioblastoma, Glioma Trial (drug, procedure, diagnostic test)

    Not yet recruiting
    • Glioblastoma
    • Glioma
    • (no location specified)
    Nov 7, 2022

    Pain Trial in Copenhagen (CT001, Placebo, Sufentanil)

    Not yet recruiting
    • Pain
    • Copenhagen, Denmark
      DanTrials
    Aug 18, 2022